Longbio Pharma (Suzhou) Co (HKSE:01779) FCF Margin %: 0.00% (As of Dec. 2025)


HKSE:01779 Longbio Pharma (Suzhou) Co Ltd HKSE:01779
10 GF Score
Price HK$157.20
View Full Analysis

What is Longbio Pharma (Suzhou) Co FCF Margin %?

Longbio Pharma (Suzhou) Co HKSE:01779 +3.63% 10 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates HKSE:01779 with a GF Score™ of 10/100. Among 960 Biotechnology companies, Longbio Pharma (Suzhou) Co ranks worse than 104166.56% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Longbio Pharma (Suzhou) Co's Free Cash Flow for the six months ended in Dec. 2025 was HK$-138.56 Mil. Longbio Pharma (Suzhou) Co's Revenue for the six months ended in Dec. 2025 was HK$0.00 Mil. Therefore, Longbio Pharma (Suzhou) Co's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Longbio Pharma (Suzhou) Co's current FCF Yield % is -1.19%.

The historical rank and industry rank for Longbio Pharma (Suzhou) Co's FCF Margin % or its related term are showing as below:


HKSE:01779's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -85.21
* Ranked among companies with meaningful FCF Margin % only.

Longbio Pharma (Suzhou) Co FCF Margin % Related Terms

Longbio Pharma (Suzhou) Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Longbio Pharma (Suzhou) Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longbio Pharma (Suzhou) Co FCF Margin % Chart

Longbio Pharma (Suzhou) Co Annual Data
Trend Dec24 Dec25
FCF Margin %
0.00 0.00

Longbio Pharma (Suzhou) Co Semi-Annual Data
Dec24 Dec25
FCF Margin % 0.00 0.00

HKSE:01779 vs : FCF Margin % Comparison

For the Biotechnology subindustry, Longbio Pharma (Suzhou) Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longbio Pharma (Suzhou) Co FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longbio Pharma (Suzhou) Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Longbio Pharma (Suzhou) Co's FCF Margin % falls into.


HKSE:01779
10GF Score
Longbio Pharma (Suzhou) Co Ltd HKSE:01779
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Longbio Pharma (Suzhou) Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Longbio Pharma (Suzhou) Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-138.56/0
= %

Longbio Pharma (Suzhou) Co's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-138.56/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Longbio Pharma (Suzhou) Co (HKSE:01779) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Longbio Pharma (Suzhou) Co and its competitors. According to the industry distribution chart, Longbio Pharma (Suzhou) Co ranks #999999 out of 960 companies in the Biotechnology industry.
Is Longbio Pharma (Suzhou) Co's FCF Margin % too high?
Longbio Pharma (Suzhou) Co's current FCF Margin % is 0.00%. Based on the distribution chart, Longbio Pharma (Suzhou) Co ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Longbio Pharma (Suzhou) Co has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Longbio Pharma (Suzhou) Co's FCF Margin % compare to ?
According to the Biotechnology industry distribution chart, Longbio Pharma (Suzhou) Co ranks #999999 out of 960 companies for FCF Margin %. This places Longbio Pharma (Suzhou) Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Longbio Pharma (Suzhou) Co and its competitors. Longbio Pharma (Suzhou) Co's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longbio Pharma (Suzhou) Co stock overvalued right now?
Longbio Pharma (Suzhou) Co (HKSE:01779) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Longbio Pharma (Suzhou) Co's overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Longbio Pharma (Suzhou) Co (HKSE:01779), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Longbio Pharma (Suzhou) Co Business Description

Comparable Companies
Address No. 128 Yinhe Road, Dongnan Subdistrict, 5th Floor, Building F, Area A, Changshu City, Jiangsu Province, Suzhou, CHN
Longbio Pharma (Suzhou) Co Ltd is a clinical-stage biotechnology company. The company and its subsidiaries are principally engaged in the research, development, manufacture and commercialisation of pharmaceutical products in the People's Republic of China (the PRC). It has developed a comprehensive product pipeline for biologic treatments targeting rhinology, dermatology, respiratory, hematology, nephrology and other autoimmune diseases, targeting allergic and autoimmune diseases. Its pipeline includes LP-003, LP-00A, LP-005, LP-00C, and LP-00D.
10GF Score

Get the complete analysis for HKSE:01779

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$157.20
Price